An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney (2016)
- Autores:
- Autores USP: FANELLI, CAMILLA - FM ; FUJIHARA, CLARICE KAZUE - FM ; ZATZ, ROBERTO - FM ; MALHEIROS, DENISE MARIA AVANCINI COSTA - FM
- Unidade: FM
- DOI: 10.1152/ajprenal.00388.2015
- Assuntos: RATOS WISTAR; RIM; HIPERTENSÃO; FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: American Journal of Physiology. Renal Physiology
- ISSN: 1931-857X
- Volume/Número/Paginação/Ano: v. 310, n. 2, p. F135-F143, 2016
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
ARIAS, Simone Costa Alarcon et al. An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney. American Journal of Physiology. Renal Physiology, v. 310, n. 2, p. F135-F143, 2016Tradução . . Disponível em: https://doi.org/10.1152/ajprenal.00388.2015. Acesso em: 24 abr. 2024. -
APA
Arias, S. C. A., Souza, R. A., Malheiros, D. M. A. C., Fanelli, C., Fujihara, C. K., & Zatz, R. (2016). An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney. American Journal of Physiology. Renal Physiology, 310( 2), F135-F143. doi:10.1152/ajprenal.00388.2015 -
NLM
Arias SCA, Souza RA, Malheiros DMAC, Fanelli C, Fujihara CK, Zatz R. An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney [Internet]. American Journal of Physiology. Renal Physiology. 2016 ; 310( 2): F135-F143.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1152/ajprenal.00388.2015 -
Vancouver
Arias SCA, Souza RA, Malheiros DMAC, Fanelli C, Fujihara CK, Zatz R. An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney [Internet]. American Journal of Physiology. Renal Physiology. 2016 ; 310( 2): F135-F143.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1152/ajprenal.00388.2015 - Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload
- Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX)
- Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD)
- Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure
- TLR2 and TLR4 play opposite role in autophagy associated with cisplatin-induced acute kidney injury
- NF-kappa B System Is Chronically Activated and Promotes Glomerular Injury in Experimental Type 1 Diabetic Kidney Disease
- NLRP3 inflammasome inhibition ameliorates tubulointerstitial injury in the remnant kidney model
- Associação terapêutica de losartan (L) e hidroclorotiazida (H) previne progressão da lesão renal em modelo de nefropatia crônica resultante da administração de (L) durante a lactação
- Pathogenic role of innate immunity in a model of chronic NO inhibition associated with salt overload
- Mechanisms of progressive renal injury in adult rats treated with losartan during lactation
Informações sobre o DOI: 10.1152/ajprenal.00388.2015 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
